Application of Critical Volume-Dose Constraints for Stereotactic Body Radiation Therapy in NRG Radiation Therapy Trials.
作者信息
Ritter Timothy A, Matuszak Martha, Chetty Indrin J, Mayo Charles S, Wu Jackie, Iyengar Puneeth, Weldon Michael, Robinson Clifford, Xiao Ying, Timmerman Robert D
机构信息
Department of Radiation Oncology, Hunter Holmes McGuire VA Medical Center, Richmond, Virginia; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; NRG Radiation Oncology Committee and/or NRG Medical Physics Subcommittee.
Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; NRG Radiation Oncology Committee and/or NRG Medical Physics Subcommittee.
出版信息
Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):34-36. doi: 10.1016/j.ijrobp.2017.01.204.
Abstract
摘要
相似文献
1
Application of Critical Volume-Dose Constraints for Stereotactic Body Radiation Therapy in NRG Radiation Therapy Trials.
Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):34-36. doi: 10.1016/j.ijrobp.2017.01.204.
2
4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.
Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):407-13. doi: 10.1016/j.ijrobp.2013.02.002. Epub 2013 Mar 21.
3
Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):188-94. doi: 10.1016/j.ijrobp.2013.04.048.
4
Optimization of stereotactic body radiotherapy treatment planning using a multicriteria optimization algorithm.
Z Med Phys. 2016 Dec;26(4):362-370. doi: 10.1016/j.zemedi.2016.04.001. Epub 2016 May 4.
5
[Lung dose constraints for normo-fractionated radiotherapy and for stereotactic body radiation therapy].
Cancer Radiother. 2017 Oct;21(6-7):584-596. doi: 10.1016/j.canrad.2017.07.046. Epub 2017 Sep 5.
6
Simultaneous integrated protection : A new concept for high-precision radiation therapy.
Strahlenther Onkol. 2016 Dec;192(12):886-894. doi: 10.1007/s00066-016-1057-x. Epub 2016 Oct 18.
7
Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and TomoTherapy stereotactic radiosurgery.
Pract Radiat Oncol. 2017 May-Jun;7(3):183-189. doi: 10.1016/j.prro.2017.01.012.
8
Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non‒small-cell lung cancer or lung metastases.
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):856-62. doi: 10.1016/j.ijrobp.2010.11.051. Epub 2011 Jan 20.
9
[Stereotactic body radiation therapy in the management of liver tumours].
Cancer Radiother. 2014 Oct;18(5-6):486-94. doi: 10.1016/j.canrad.2014.07.145. Epub 2014 Sep 5.
10
Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: a planning study on treatment concepts.
Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):264-70. doi: 10.1016/j.ijrobp.2012.02.036. Epub 2012 Apr 18.
引用本文的文献
1
Dosimetric investigation of couch rotation angles in non-coplanar VMAT plans for lung cancer SBRT.
Front Oncol. 2024 Dec 24;14:1454676. doi: 10.3389/fonc.2024.1454676. eCollection 2024.
2
The potential of integrating stereotactic ablative radiotherapy techniques with hyperfractionation for lung cancer.
Thorac Cancer. 2024 Aug;15(22):1679-1687. doi: 10.1111/1759-7714.15335. Epub 2024 Jun 17.
3
Radiation-induced lung injury - what do we know in the era of modern radiotherapy?
Rep Pract Oncol Radiother. 2022 Jul 29;27(3):552-565. doi: 10.5603/RPOR.a2022.0046. eCollection 2022.
4
Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers.
Front Oncol. 2021 May 24;11:674731. doi: 10.3389/fonc.2021.674731. eCollection 2021.
5
Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy.
BMC Cancer. 2021 Apr 14;21(1):405. doi: 10.1186/s12885-021-08020-2.
6
An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer.
Adv Radiat Oncol. 2021 Jan 20;6(2):100653. doi: 10.1016/j.adro.2021.100653. eCollection 2021 Mar-Apr.
7
Radiation-induced lung toxicity - cellular and molecular mechanisms of pathogenesis, management, and literature review.
Radiat Oncol. 2020 Sep 10;15(1):214. doi: 10.1186/s13014-020-01654-9.
8
Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy.
Front Oncol. 2020 May 20;10:786. doi: 10.3389/fonc.2020.00786. eCollection 2020.
9
Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.
BMC Cancer. 2019 Aug 19;19(1):816. doi: 10.1186/s12885-019-5977-6.
10
Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?
Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):172-187. doi: 10.1016/j.ijrobp.2018.11.028. Epub 2018 Nov 26.
本文引用的文献
1
Stereotactic body radiotherapy for primary hepatic malignancies - Report of a phase I/II institutional study.
Radiother Oncol. 2016 Oct;121(1):79-85. doi: 10.1016/j.radonc.2016.07.020. Epub 2016 Aug 23.
2
Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice review.
Pract Radiat Oncol. 2016 Jul-Aug;6(4):e117-e126. doi: 10.1016/j.prro.2015.11.001. Epub 2016 Jan 26.
3
Stereotactic body radiation therapy: the report of AAPM Task Group 101.
Med Phys. 2010 Aug;37(8):4078-101. doi: 10.1118/1.3438081.
4
A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases.
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1371-8. doi: 10.1016/j.ijrobp.2005.01.002.
Zotero 插件